APA (7th ed.) Citation

AV, S., RT, W., E, G., W, A., S, R., B, M., . . . AE, P. (2021). Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: A single-centre, prospective 1-year observational cohort study of the first 100 patients treated. The British journal of dermatology, 184(4), 755. https://doi.org/10.1111/bjd.19631

Chicago Style (17th ed.) Citation

AV, Sears, Woolf RT, Gribaleva E, Abdelrahman W, Robbie S, Menon B, Kirkham B, Smith CH, and Pink AE. "Real-world Effectiveness and Tolerability of Dupilumab in Adult Atopic Dermatitis: A Single-centre, Prospective 1-year Observational Cohort Study of the First 100 Patients Treated." The British Journal of Dermatology 184, no. 4 (2021): 755. https://doi.org/10.1111/bjd.19631.

MLA (9th ed.) Citation

AV, Sears, et al. "Real-world Effectiveness and Tolerability of Dupilumab in Adult Atopic Dermatitis: A Single-centre, Prospective 1-year Observational Cohort Study of the First 100 Patients Treated." The British Journal of Dermatology, vol. 184, no. 4, 2021, p. 755, https://doi.org/10.1111/bjd.19631.